Clinical effect and safety evaluation of different dosage of Rituximab combined with Cyclophosphamide in treatment of refractory immune Thrombocytopenia

OBJECTIVE: To discuss clinical effect of different dosage of rituximab combined with cyclophosphamide in treatment of refractory immune thrombocytopenia (rITP). METHOD: This study was conducted at Department of Hematopathology in XX Hospital from January 2016 to January 2018. In this study. Seventy-...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhibin, Ren, Yu, Li, Mingwei, Huang, Weibo, Yao, Haiying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994893/
https://www.ncbi.nlm.nih.gov/pubmed/32063934
http://dx.doi.org/10.12669/pjms.36.2.1168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994893/
https://www.ncbi.nlm.nih.gov/pubmed/32063934
http://dx.doi.org/10.12669/pjms.36.2.1168

Ejemplares similares